Company Analysis
Sign in

Pacira BioSciences, Inc. (PCRX)

Nasdaq: PCRX · Pharmaceutical Preparations · Brisbane, CA · filing with the SEC since 2007
Full chart Alerts Compare
Grade6.3
◀ Past 8.0● Present 6.1▶ Future 4.9
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

93 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Pacira BioSciences, Inc.’s names, not what it holds today.

Patents granted
93
88 utility, 5 design, 1976 to Dec 31, 2025
Granted in 2025
16
Against 17 in 2024 and 14 in 2023
Applications published
100
7 of them in 2025
Names they are printed under
6
a former name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology24
Pharmaceuticals24
Chemical engineering12
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
Pacira Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
57 granted
26 published
Pacira CryoTech, Inc. a subsidiary
US, as the owner printed on each patent
35 granted
24 published
Pacira Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
0 granted
42 published
Pacira CryoTech, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
Pacira Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
Pacira Therapeutics, Inc. a subsidiary
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 30, 202512,508,062Cryogenic therapy systems and methodsMedical technologyPacira CryoTech, Inc.
Nov 18, 202512,471,977Secure cryosurgical treatment systemMedical technologyPacira CryoTech, Inc.
Nov 4, 202512,458,530Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritisMedical technologyPacira CryoTech, Inc.
Nov 4, 202512,458,424Stabilizing pressure in cryogenic devicesMedical technologyPacira CryoTech, Inc.
Oct 7, 202512,433,878Uses of bupivacaine multivesicular liposomes as stellate ganglion blockPharmaceuticalsPacira Pharmaceuticals, Inc.
Jul 29, 202512,370,142Manufacturing of bupivacaine multivesicular liposomesPharmaceuticalsPacira Pharmaceuticals, Inc.
Jul 22, 202512,364,764Sustained release thermosetting gels comprising sodium channel blockers and the methods of making samePharmaceuticalsPacira Therapeutics, Inc.
Jun 3, 202512,318,483Manufacturing of bupivacaine multivesicular liposomesPharmaceuticalsPacira Pharmaceuticals, Inc.
May 13, 202512,296,047Manufacturing of bupivacaine multivesicular liposomesChemical engineeringPacira Pharmaceuticals, Inc.
Apr 29, 202512,285,435Multivesicular liposome formulations of dexamethasonePharmaceuticalsPacira Pharmaceuticals, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 20, 20252025/0352474MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMESPharmaceuticalsPacira Pharmaceuticals, Inc.
Nov 20, 20252025/0352471MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMESPharmaceuticalsPacira Pharmaceuticals, Inc.
Nov 20, 20252025/0352470MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMESPharmaceuticalsPacira Pharmaceuticals, Inc.
May 22, 20252025/0161284USES OF BUPIVACAINE MULTIVESICULAR LIPOSOMES AS STELLATE GANGLION BLOCK FOR TREATING DISORDERS ASSOCIATED WITH SYMPATHETIC NERVOUS SYSTEMPharmaceuticalsPacira Pharmaceuticals, Inc.
May 1, 20252025/0134814MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMESChemical engineeringPacira Pharmaceuticals, Inc.
Feb 27, 20252025/0064742MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMESChemical engineeringPacira Pharmaceuticals, Inc. · patent 12,296,047 granted from it
Feb 20, 20252025/0057577INTEGRATED COLD THERAPY AND ELECTRICAL STIMULATION SYSTEMS FOR LOCATING AND TREATING NERVES AND ASSOCIATED METHODSMedical technologyPacira CryoTech, Inc.
Dec 12, 20242024/0408015MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMESChemical engineeringPacira Pharmaceuticals, Inc. · patent 12,178,909 granted from it
Dec 5, 20242024/0399100INTRAARTICULAR POSTEROMEDIAL LANDMARK INJECTION FOR LOWER EXTREMITY ANALGESIAPharmaceuticalsPacira Pharmaceuticals, Inc.
Dec 5, 20242024/0398461Methods and Systems for Locating and Treating Nerves With Cold TherapyMedical technologyPacira CryoTech, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 10 · Medical technology 6 · Chemical engineering 3.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton PCRX · research, not advice